Newamsterdam Pharma Stock Technical Analysis
| NAMS Stock | 21.05 0.85 4.21% |
As of the 26th of November, NewAmsterdam Pharma secures the Downside Deviation of 3.74, mean deviation of 2.34, and Risk Adjusted Performance of 0.105. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewAmsterdam Pharma, as well as the relationship between them. Please verify NewAmsterdam Pharma jensen alpha and downside variance to decide if NewAmsterdam Pharma is priced some-what accurately, providing market reflects its recent price of 21.05 per share. Given that NewAmsterdam Pharma has jensen alpha of 0.1772, we recommend you to check NewAmsterdam Pharma's last-minute market performance to make sure the company can sustain itself at a future point.
NewAmsterdam Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NewAmsterdam, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NewAmsterdamNewAmsterdam |
NewAmsterdam Pharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 25.16 | Strong Buy | 9 | Odds |
Most NewAmsterdam analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NewAmsterdam stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NewAmsterdam Pharma, talking to its executives and customers, or listening to NewAmsterdam conference calls.
NewAmsterdam Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NewAmsterdam Pharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of NewAmsterdam Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
NewAmsterdam Pharma Trend Analysis
Use this graph to draw trend lines for NewAmsterdam Pharma. You can use it to identify possible trend reversals for NewAmsterdam Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NewAmsterdam Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.NewAmsterdam Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NewAmsterdam Pharma applied against its price change over selected period. The best fit line has a slop of 0.13 , which means NewAmsterdam Pharma will continue generating value for investors. It has 122 observation points and a regression sum of squares at 658.5, which is the sum of squared deviations for the predicted NewAmsterdam Pharma price change compared to its average price change.About NewAmsterdam Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NewAmsterdam Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NewAmsterdam Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NewAmsterdam Pharma price pattern first instead of the macroeconomic environment surrounding NewAmsterdam Pharma. By analyzing NewAmsterdam Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NewAmsterdam Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NewAmsterdam Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Graham Number | 13.04 | 10.2 | Receivables Turnover | 41.7 | 37.06 |
NewAmsterdam Pharma November 26, 2024 Technical Indicators
Most technical analysis of NewAmsterdam help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NewAmsterdam from various momentum indicators to cycle indicators. When you analyze NewAmsterdam charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.105 | |||
| Market Risk Adjusted Performance | 0.2067 | |||
| Mean Deviation | 2.34 | |||
| Semi Deviation | 3.31 | |||
| Downside Deviation | 3.74 | |||
| Coefficient Of Variation | 787.0 | |||
| Standard Deviation | 3.59 | |||
| Variance | 12.9 | |||
| Information Ratio | 0.0912 | |||
| Jensen Alpha | 0.1772 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0877 | |||
| Treynor Ratio | 0.1967 | |||
| Maximum Drawdown | 29.23 | |||
| Value At Risk | (3.97) | |||
| Potential Upside | 5.33 | |||
| Downside Variance | 13.97 | |||
| Semi Variance | 10.97 | |||
| Expected Short fall | (2.57) | |||
| Skewness | (0.52) | |||
| Kurtosis | 7.36 |
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.